We are participating in the upcoming World Drug Safety Congress Europe 2022. Fill out and submit the form to schedule a meeting with our experts – Hans Buchmeiser, Vice President, Business Development, Europe and Dr. Kanwalpreet Kaur, QPPV and Senior Medical Safety Lead, at the event.
The World Drug Safety Congress is one of the largest conferences attended by key players across the pharma industry. It brings together more than 700+ key thought leaders from Biopharma companies to explore challenges within pharmacovigilance. This year, WDSC focuses on addressing key challenges and use of big data, AI in pharmacovigilance, examine benefit-risk management strategies and patient-centric approaches. The conference also discuss how one can tackle the challenges of social media and drug safety legislation globally.